Research Programmes / Core Facilities

Vacant position
Nick Berrow
Camille Stephan-Otto Attolini
Mouse Mutant Core Facility

Research Programmes

  • Cell and Developmental Biology
    More about Cell and Developmental Biology
  • Structural and Computational Biology
    More about Structural and Computational Biology
  • Molecular Medicine
    More about Molecular Medicine
  • Chemistry and Molecular Pharmacology
    More about Chemistry and Molecular Pharmacology
  • Oncology
    More about Oncology

Core Facilities & Services

Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.

Interdisciplinary initiatives

IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine

Selected IRB Barcelona publications

Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Cañellas A, Hernando-Momblona X, Byrom D, Matarin JA, Calon A, Rivas EI, Nebreda AR, Riera A, Attolini CS and Batlle E.
Nature, 554 (7693), 538-543 (2018)
Silva J, Aivio S, Knobel PA, Bailey LJ, Casali A, Vinaixa M, Garcia-Cao I, Coyaud É, Jourdain AA, Pérez-Ferreros P, Rojas AM, Antolin-Fontes A, Samino-Gené S, Raught B, González-Reyes A, Ribas de Pouplana L, Doherty AJ, Yanes O and Stracker TH.
Nat Cell Biol, 20 (2), 162-174 (2018)
Pluta R, Boer DR, Lorenzo-Díaz F, Russi S, Gómez H, Fernández-López C, Pérez-Luque R, Orozco M, Espinosa M and Coll M.
P Natl Acad Sci Usa, 114 (32), E6526-E653 (2017)
<p>Natcom</p>
Bayona-Feliu A, Casas-Lamesa A, Reina O, Bernués J and Azorín F.
Nat Commun, 8 (1), 283 (2017)
Solanas G, Peixoto FO, Perdiguero E, Jardí M, Ruiz-Bonilla V, Datta D, Symeonidi A, Castellanos A, Welz PS, Caballero JM, Sassone-Corsi P, Muñoz-Cánoves P and Benitah SA.
Cell, 170 (4), 678-692.e2 (2017)
Weill L, Belloc E, Castellazzi CL and Méndez R.
Nat Struct Mol Biol, 24 (8), 672-681 (2017)
Testoni G, Duran J, García-Rocha M, Vilaplana F, Serrano AL, Sebastián D, López-Soldado I, Sullivan MA, Slebe F, Vilaseca M, Muñoz-Cánoves P and Guinovart JJ.
Cell Metab, 26 (1), 256-266.e4 (2017)
Ramírez S, Gómez-Valadés AG, Schneeberger M, Varela L, Haddad-Tóvolli R, Altirriba J, Noguera E, Drougard A, Flores-Martínez Á, Imbernón M, Chivite I, Pozo M, Vidal-Itriago A, Garcia A, Cervantes S, Gasa R, Nogueiras R, Gama-Pérez P, Garcia-Roves PM, Cano DA, Knauf C, Servitja JM, Horvath TL, Gomis R, Zorzano A* and Claret M.*
Cell Metab, 25 (6), 1390-1399. (2017)
Villanueva E, Navarro P, Rovira-Rigau M, Sibilio A, Méndez R and Fillat C.
Nat Commun, 8 14833 (2017)
Barriga FM, Montagni E, Mana M, Mendez-Lago M, Hernando-Momblona X, Sevillano M, Guillaumet-Adkins A, Rodriguez-Esteban G, Buczacki SJA, Gut M, Heyn H, Winton DJ, Yilmaz OH, Attolini CS, Gut I and Batlle E.
Cell Stem Cell, 20 (6), 801-816.e7 (2017)
Picco A, Irastorza-Azcarate I, Specht T, Böke D, Pazos I, Rivier-Cordey AS, Devos DP, Kaksonen M and Gallego O.
Cell, 168 (3), 400-412.e1 (2017)
Marcos E, Basanta B, Chidyausiku TM, Tang Y, Oberdorfer G, Liu G, Swapna GV, Guan R, Silva DA, Dou J, Pereira JH, Xiao R, Sankaran B, Zwart PH, Montelione GT and Baker D.
Science, 355 (6321), 201-206 (2017)
Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescós C, Di Croce L and Benitah SA.
Nature, 541 (7635), 41-45 (2017)

Noticias

<p>The graphic shows a new class of prolyl oligopeptidase (POP) inhibitor. The inhibitor is able to reach the brain and bind to the POP protein, In yellow/red, the reactive group of the inhibitor that bind to the catalytic site of the protein (S Guardiola)</p>
17 May 2018

An article published in Cell Chemical Biology by scientists at the Institute for Research in Biomedicine (IRB Barcelona) describes a new class of prolyl oligopeptidase (POP) inhibitors.

<p>Normal Drosophila melanogaster spermatozoa. Orange shows heads and green shows tails. Photo courtesy of S. Llamazares / Gonzalez Lab</p>
11 May 2018

The group led by ICREA Research Professor Cayetano Gonzalez at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with Giuliano Callaini’s team at the University of Siena i

8 May 2018

The European Research Council (ERC) has announced the first round of 2018 ERC Proof of

<p>Mouse cells with DOR protein. (M. Romero, IRB Barcelona)</p>
19 Apr 2018

Obesity is a world health problem since excessive accumulation of fat tissue (or adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer.

Events

23 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Professor Gábor Juhász Biological Research Centre of the Hungarian Academy of Sciences, Szeged & Eötvös Loránd University, Budapest
25 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Prof. Dr. Martin Eilers. Department of Biochemistry and Molecular Biology Biocenter, University of Würzburg. Würzburg, Germany
30 May
Aula Fèlix Serratosa, Parc Científic de Barcelona
Speaker:
Carlos Fernández-Hernando, PhD - Associate Professor (Tenure). Vascular Biology & Therapeutics Program (VBT) Departments of Comparative Medicine and Pathology Integrative Cell Signaling & Neurobiology Metabolism Program (ICSNM) Yale University School of M